[1]
2025. PO49 | Use of emicizumab in two patients with acquired hemophilia A: a new therapeutic approach: S. Sorella, J. Micozzi, E. Baldacci, M. Biglietto, R. Mormile, A. Chistolini, R. Ciciani, L. Torrieri, N. Zhdanovskaya, M. Lorenzon, A. Delli Paoli, S. Ligia, C. Santoro | Hematology, Department of Translational and Precision Medicine, Policlinico Umberto I, Sapienza University of Roma, Italy. Bleeding, Thrombosis and Vascular Biology. 4, s1 (Aug. 2025). DOI:https://doi.org/10.4081/btvb.2025.318.